ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.96M | 2.01M | 1.85M | 1.85M | 1.56M |
| Total Other Revenue | -- | -- | -27.00K | -27.00K | 26.70K |
| Total Revenue | 1.96M | 2.01M | 1.82M | 1.82M | 1.56M |
| Cost of Revenue | 233.60K | 240.20K | 224.70K | 224.30K | 205.90K |
| Gross Profit | 1.72M | 1.77M | 1.60M | 1.60M | 1.35M |
| SG&A Expenses | 4.57M | 4.70M | 3.87M | 3.86M | 4.88M |
| Depreciation & Amortization | 719.10K | 739.40K | 358.80K | 358.10K | 379.30K |
| Other Operating Expenses | 205.90K | 211.70K | 1.01M | 1.00M | 124.50K |
| Total Operating Expenses | 5.73M | 5.89M | 5.49M | 5.48M | 5.59M |
| Operating Income | -3.77M | -3.88M | -3.66M | -3.66M | -4.03M |
| Income Before Tax | -3.63M | -3.73M | -3.31M | -3.31M | -3.16M |
| Income Tax Expenses | 3.60K | 3.70K | 4.30K | 4.30K | 6.50K |
| Earnings from Continuing Operations | -3.63M | -3.73M | -3.32M | -3.31M | -3.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.63M | -3.73M | -3.32M | -3.31M | -3.17M |
| EBIT | -3.77M | -3.88M | -3.66M | -3.66M | -4.03M |
| EBITDA | -3.05M | -3.14M | -3.57M | -3.47M | -3.65M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.02T | 2.02T | 2.05B | 2.05B | 2.02T |
| Average Diluted Shares Outstanding | 2.02T | 2.02T | 2.05B | 2.05B | 2.02T |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
